Welcome to the UK NEQAS for H & I website.
The UK National Quality Assessment Service for Histocompatibility and Immunogenetics (UK NEQAS for H&I) provides a comprehensive range of External Quality Assessment (EQA) Schemes for laboratories operating clinical histocompatibility and immunogenetics (H&I) services.
Schemes are available to all clinical laboratories in the UK and overseas and appropriate biotechnology companies.
H&I laboratory support is universally required for both solid organ and haemopoietic stem cell (HSC) transplant programmes and for HLA typing for disease susceptibility and diagnosis, pharmacogenetics, volunteer HSC donor panels and HLA 'matched' blood products. The primary laboratory investigations are the determination of subjects' HLA type, HLA antibody detection and specification and the direct crossmatching of patients' sera against donor cells.
UK NEQAS for H&I is hosted by the Welsh Blood Service and operates within the Welsh Transplantation and Immunogenetics Laboratory.
UK NEQAS for H&I operates under the UK NEQAS code of practice and is accredited by Clinical Laboratory Accreditation Ltd.
Full details of UK NEQAS for H&I's EQA schemes are given in its Prospectus.